Viking Therapeutics VKTX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's change in AP?
- Viking Therapeutics (VKTX) reported change in AP of $13.93M in Q1 2026.
- How has Viking Therapeutics's change in AP changed year-over-year?
- Viking Therapeutics's change in AP increased by 760.2% year-over-year, from -$2.11M to $13.93M.
- What is the long-term trend for Viking Therapeutics's change in AP?
- Over 2 years (2021 to 2025), Viking Therapeutics's change in AP has grown at a 313.2% compound annual growth rate (CAGR), from -$2.54M to $43.44M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.